"Miracle Doctor" Dr. Wei-Hua Chen: Role of Oligo Fucoidan in Cancer Care

LOS ANGELES, March 19, 2025 /PRNewswire/ -- Dr. Wei-Hua Chen, a renowned 70-year-old cardiologist and the director of Hongxin Clinic (Taichung, Taiwan), has been awarded the "28^th Fervent Global Love of Lives Award 2025" by the Chou Ta-Kuan Cultural and Educational Foundation. First diagnosed with cancer at the age of 32, he had battled four different types of cancer over the course of two decades. His remarkable resilience and dedication to patient care, rural medicine, and global advocacy have earned him the title of "Miracle Doctor."

A Survivor's Mission: Turning Adversity into Advocacy

Having battled cancer firsthand, Dr. Chen developed a three-pillar approach to cancer management:

1. Optimized Nutrition & Lifestyle Adjustments – Eliminating harmful habits while embracing nutrient-rich foods.
2. Mindset & Emotional Resilience – Managing stress and cultivating a positive mindset.
3. Science-Driven Supplementation – Supporting immunity and recovery with clinically validated, research-backed nutritional support.

A Holistic Approach in Cancer Treatment

As both a dedicated physician and the brand ambassador of Hi-Q Marine Biotech, Dr. Chen emphasizes the importance of choosing scientifically validated in cancer care. He has personally experienced and observed in fellow patients the benefits of OliFuco® Oligo Fucoidan, a small-molecular-weight marine-derived polysaccharide from kelp, in strengthening the immune system, enhancing treatment response, and mitigating cancer therapy side effects.

Beyond physical health, Dr. Chen underscores the vital role of mental well-being. Initially devastated by his diagnosis, he found strength in faith, music, and mindfulness. He also credits OliFuco® supplement for helping him maintain a higher quality of life throughout his cancer treatments. Today, he continues to inspire patients to embrace a balanced lifestyle and a proactive approach to health.

The Existing Gap in Cancer Care

Ensuring access to proper nutrition and supplemental interventions is fundamental to quality cancer care. Cancer treatment often leaves patient numerous side effects, including fatigue, malnutrition and fast loss of muscle, with cachexia contributing to 20% of cancer-related deaths. Research shows that early and proactive nutritional support—combined with standard therapy—improves treatment outcomes and enhances patient well-being.

Dr. Chen highly recommends OliFuco® supplement for its superior bioavailability, high absorbability and extensive scientific research.

"Hi-Q has conducted over 15 human clinical trials, focusing on colorectal cancer, lung cancer, and liver cancer, among others," said Dr. Yen, Hi-Q's Chief Research Officer and an esteemed oncologist. "Our first clinical evidence on cancer support conducted in Kaohsiung Medical University Chung-Ho Memorial Hospital was published in 2017. Today, there are over 60 scientific publication confirming the role of our Oligo Fucoidan in improving cancer treatment outcomes and supporting chronic disease management."

Furthermore, the U.S. National Cancer Institute (NCI) has listed Oligo Fucoidan in its Drug Dictionary, recognizing its potential in cancer-related applications. These endorsements highlight the importance of scientific validation in nutritional support, reinforcing Hi-Q's commitment to research-driven innovation.

SOURCE Hi-Q Marine Biotech International Ltd